- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge revenues grow during second quarter
Merge revenues grow during second quarterConnectivity and PACS firm Merge Technologies reported preliminary results for its second quarter that will be below analysts’ expectations, according to the company. The Milwaukee, WI-based vendor
Merge revenues grow during second quarter
Connectivity and PACS firm Merge Technologies reported preliminary results for its second quarter that will be below analysts expectations, according to the company. The Milwaukee, WI-based vendor expects revenue to be approximately $2.8 million, a 47% increase compared with the $1.9 million reported in the same period last year. Merge anticipates a net loss of 8 cents to 11 cents a share for the quarter (end-June). The company had a net loss of 12 cents per share in the same period in 1998.
In other Merge news, the company has installed its 275th MergeWorks DICOM clinical imaging network in the U.S. Merge began shipping MergeWorks in the U.S. in 1996. Earlier this year, Merge began offering MergeWorks in Europe, and the company has installed networks at five European sites. In the second quarter, the firms systems solutions division posted a 70% increase in revenue compared with the same period in 1998.
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
